Timing of Access Closure in Transfemoral Impella Care

Timing of Access Closure in Transfemoral Impella Care - TACTIC

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00040212

Enrollment

100

Registered

2026-05-27

Start date

2026-08-03

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

R57.0

Interventions

Group 1: 50 patients with deployment of the suture-based vascular closure system already at the time of Impella implantation Group 2: 50 patients with deployment of the suture-based vascular closure s

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Transfemoral Impella implantation

Exclusion criteria

Exclusion criteria: - Mechanical aortic valve replacement - Severe peripheral arterial disease precluding transfemoral Impella implantation

Design outcomes

Primary

Measure	Time frame
Composite endpoint of bleeding events =BARC 3a, vascular and access-site-related complications excluding bleeding, and 30-day all-cause mortality	—

Secondary

Measure	Time frame
- Life-threatening bleeding events (BARC 3b/5) - Major bleeding events (BARC 3a) - Major vascular and access-site-related complications, excluding bleeding - Minor vascular and access-site-related complications, excluding bleeding - Need for transfusion - Length of hospital stay - 30-day all-cause mortality	—

Countries

Germany

Contacts

Public ContactEbe Amr

Universitätsklinikum Heidelberg - Abteilung für Kardiologie, Angiologie und Pneumologie

ebe.amr@med.uni-heidelberg.de+49 6221 56 36236

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 11, 2026